Knock-in mouse for modelling blockade of human tnfalpha
EP2233502A1
Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them
EP2113568A1
Knock-in mouse for modelling blockade of human TNFalpha
EP2115128A2
Method for modulating the immune response by activating or inactivating the notch and/or stat4 signal path
EP2073005A1
Method for in-vitro detecting pathogenic T helper cells and pharmaceutical compositions for treating autoimmune diseases
WO2007110249A1
Use of the 4-1bb receptor for identifying and/or separating activated regulatory th cells (treg)
EP1840569A1
Utilisation of the 4-1BB receptor for identifying and/or separating activated regulatory Th-cells (Treg)
DE102006014193A1
Use of 4-1BB receptor for identification and/or separation of regulatory Th-cell such as D4+, CD25+, FoxP3+, living regulatory Th-cell, antigen-specific regulatory Th-cell or activated regulatory Th-cell
EP1536230A1
Flow cytometric, particle-based binding assay
EP1420253A1
Method of detecting and isolating T-lymphocytes that recognize a defined antigen
DE19636252A1
Combined pharmaceutical preparation for the treatment of rheumatic diseases
DE4438767A1
Combined pharmaceutical preparations comprising a hepatoprotective compound
DE4411588C1
Buffer, contg. betaine, for RNA- and DNA-polymerase reactions
DE4341479A1
Antiviral therapy using metallo:thioneine and apo:thioneine
DE4336640A1
Metal chelates, process for the preparation thereof and the use thereof as antiviral pharmaceuticals
DE4336642A1
Use of vanadium compounds with antiviral activity
DE4336641A1
Use of superoxide dismutase (SOD) for the treatment of retroviral diseases
